Amphotericin B up-regulates lipid A-induced IL-6 production via caspase-8

R Tamai1, M Sugamata, Y Kiyoura

  • 1Department of Oral Medical Science, Ohu University School of Dentistry, 31-1 Misumido, Tomitamachi, Koriyama, Fukushima 963-8611, Japan.

Insights

Amphotericin B enhances the inflammatory response to bacterial components like lipid A. This interaction, dependent on cell membrane cholesterol, involves caspase-8 and may be mitigated by prior periodontal treatment.

Area of Science:

  • Immunology
  • Pharmacology
  • Microbiology

Background:

  • Amphotericin B, an antifungal, can stimulate pro-inflammatory cytokines.
  • Lipid A from Gram-negative bacteria is a potent immune activator.

Purpose of the Study:

  • To investigate how amphotericin B affects lipid A-induced cytokine production.
  • To explore the mechanisms underlying this synergistic effect.

Main Methods:

  • Human gingival fibroblasts were treated with amphotericin B and lipid A.
  • Levels of interleukin (IL)-6, IL-8, and nuclear factor (NF)-κB activation were measured.
  • The role of cholesterol-rich microdomains and caspase-8 was assessed using methyl-β-cyclodextrin and inhibitors.

Main Results:

  • Amphotericin B alone caused minor IL-6 and IL-8 increases.
  • It synergistically amplified lipid A-induced IL-6, IL-8, and NF-κB activation.
  • This synergy was dependent on cholesterol-rich microdomains and mediated by caspase-8.

Conclusions:

  • Amphotericin B potentiates lipid A-induced inflammation via cholesterol-dependent pathways and caspase-8.
  • Periodontal treatment before amphotericin B may offer protection against this inflammatory response.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...